Health The prevalence of obesity increased by over 20% under the new classification. The corporate offices of Massachusetts General Brigham hospitals in Assembly Square in Somerville. Lane Turner/The Boston Globe A new Mass General Brigham study found a large increase in the number of U.S. adults who meet the new definition of obesity. The Lancet Diabetes and Endocrinology Commission recently …
Read More »Tag Archives: obesity
Study Indicates Dramatic Increase in Percentage of U.S. Adults Who Meet New Definition of Obesity
Mass General Brigham researchers studied a new definition of obesity that moves beyond BMI to include measures of body fat distribution Applying the updated criteria to a national study population revealed a nearly 60 percent rise in obesity prevalence, affecting up to 80 percent of older adults The prevalence of obesity in the United States …
Read More »Almost 70% of US adults would be deemed obese based on new definition, study finds | Obesity
Almost 70% of adults in the US would be deemed to have obesity based on a new definition, research suggests. The traditional definition of obesity, typically based on having a body mass index (BMI) of 30 or greater, has long been contentious, not least as it does not differentiate between fat and muscle. In an effort to tackle the issue, …
Read More »Effect of sweeteners and sweetness enhancers on weight management and gut microbiota composition in individuals with overweight or obesity: the SWEET study
Ethics statement This trial has been registered at ClinicalTrials.gov (NCT04226911), was approved by national ethical committees (protocols and amendments) and was conducted in accordance with the Declaration of Helsinki. The study was monitored for Good Clinical Practice compliance by the European Clinical Research Infrastructure Network, as described previously18. All participants provided written informed consent. Trial design The SWEET trial was …
Read More »Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say – Reuters
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say Reuters A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults Nature Semaglutide, tirzepatide recommended as first-line treatment of obesity and most of its complications in new guidance Medical Xpress Weight loss jabs Mounjaro and Wegovy are so effective they should be the …
Read More »How weight-loss injections are making obesity a wealth issue
Nick TriggleHealth correspondent BBC Three years ago, a fashion editor friend returned from Milan Fashion Week bursting with a story to tell. Most fashion editors stayed at the same hotel, she explained, and each bedroom had its own mini fridge. After checking out, en route to the airport, a stylist in her party cried out that he’d left “an important …
Read More »This Hated Stock Suddenly Looks Like an Obesity Bargain – The Wall Street Journal
This Hated Stock Suddenly Looks Like an Obesity Bargain The Wall Street Journal Can PFE Successfully Return to the Obesity Space With Metsera Buyout? Yahoo Finance Pfizer’s weight-loss drug confines it to sidelines of crowded market Financial Times Pfizer amps up push into obesity treatments with $4.9B deal for Metsera ABC News – Breaking News, Latest News and Videos Metsera Stock Jumps 60%. Pfizer …
Read More »Eli Lilly plans $6.5 billion Texas manufacturing plant for obesity pill
A rendering of Eli Lilly’s manufacturing facility in Houston, Texas. Courtesy: Eli Lilly Eli Lilly on Tuesday said it will spend $6.5 billion to build a manufacturing facility in Houston, Texas, to boost production of the company’s pipeline of so-called small molecule drugs, including its closely watched experimental obesity pill. It is the second in a string of new planned …
Read More »Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
Proposed acquisition to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer’s pipeline Transaction valued at $47.50 per Metsera share in cash upon closing, for an initial enterprise value of $4.9 billion with a CVR of up to $22.50 per share in additional payments Pfizer to host a public webcast at 8 am EDT today NEW YORK–(BUSINESS WIRE)– …
Read More »How do weight loss medications affect our relationship with food? | Obesity
1. Reduced hunger Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and tirzepatide (Mounjaro) have been shown to help people living with obesity lose weight. By mimicking the action of a hormone called GLP-1, they reduce appetite and feelings of hunger, slow the release of food from the stomach and increase feelings of fullness after eating. “It works by …
Read More »